Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Briacell Therapeutics Corp (BCTX)

Briacell Therapeutics Corp (BCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
BriaCell and BriaPro Enter Into Asset Purchase Agreement for Exclusive Soluble CD80 License GlobeNewswire - Wed Feb 18, 4:30PM CST

PHILADELPHIA and VANCOUVER, British Columbia, Feb. 18, 2026 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW, BCTXZ, BCTXL) (TSX: BCT) (“ BriaCell ”), a clinical-stage biotechnology...

BCT.TO : 5.64 (+3.49%)
BCTXW : 0.0060 (+3.45%)
BCTXZ : 0.1453 (+3.79%)
BCTXL : 1.0000 (-3.85%)
BCTX : 4.13 (+3.51%)
BriaCell Receives Positive Recommendation from Data Safety Monitoring Board (DSMB) for Phase 3 Study in Metastatic Breast Cancer GlobeNewswire - Tue Feb 17, 6:30AM CST

Independent DSMB has identified no safety concerns, and recommends continuation of BriaCell’s pivotal Phase 3 study of Bria-IMT™ plus immune check point inhibitor Fifth consecutive positive DSMB...

BCT.TO : 5.64 (+3.49%)
BCTXW : 0.0060 (+3.45%)
BCTXZ : 0.1453 (+3.79%)
BCTXL : 1.0000 (-3.85%)
BCTX : 4.13 (+3.51%)
BriaCell Patients’ Images Show Regression and Resolution of Metastasized Tumors and Immune Activation GlobeNewswire - Wed Jan 28, 6:30AM CST

Images below confirm clinical responses seen in patients with metastatic orbital (eye), temporal (brain), liver, and spine lesions No Bria-IMT™ related discontinuations reported to date Bria-IMT...

BCT.TO : 5.64 (+3.49%)
BCTXW : 0.0060 (+3.45%)
BCTXZ : 0.1453 (+3.79%)
BCTXL : 1.0000 (-3.85%)
BCTX : 4.13 (+3.51%)
BriaCell Highlights Extended >18-47 Months Survival in Phase 2 Metastatic Breast Cancer Patients GlobeNewswire - Tue Jan 27, 6:30AM CST

9 of 25 BriaCell patients treated since 2022   remain alive >18-47 months post enrollment, markedly exceeding benchmarks reported for standard of care therapies in similar patient populations ...

BCT.TO : 5.64 (+3.49%)
BCTXW : 0.0060 (+3.45%)
BCTXZ : 0.1453 (+3.79%)
BCTXL : 1.0000 (-3.85%)
BCTX : 4.13 (+3.51%)
BriaCell Therapeutics Announces Closing of US$30 million Public Offering GlobeNewswire - Thu Jan 15, 3:05PM CST

PHILADELPHIA and VANCOUVER, British Columbia, Jan. 15, 2026 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXL) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology...

BCT.TO : 5.64 (+3.49%)
BCTXW : 0.0060 (+3.45%)
BCTXZ : 0.1453 (+3.79%)
BCTXL : 1.0000 (-3.85%)
BCTX : 4.13 (+3.51%)
The $69B Precision Pivot: Why Biomarker Platforms are Igniting a New Oncology Gold Rush BayStreet.ca - Wed Jan 14, 8:56AM CST

Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – Baystreet.ca News Commentary – The genomics in cancer care market is on a massive tear, projected to hit $69.16 billion by 2032 as doctors...

ONCY : 1.0000 (-1.96%)
BCT.TO : 5.64 (+3.49%)
ACRV : 1.5800 (-0.63%)
LLY : 1,023.22 (+0.26%)
BCTX : 4.13 (+3.51%)
GLSI : 24.93 (+1.80%)
CATX : 5.65 (+12.33%)
BriaCell Therapeutics Announces Pricing of $30 million Public Offering GlobeNewswire - Tue Jan 13, 8:00PM CST

PHILADELPHIA and VANCOUVER, British Columbia, Jan. 13, 2026 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXL) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology...

BCT.TO : 5.64 (+3.49%)
BCTXW : 0.0060 (+3.45%)
BCTXZ : 0.1453 (+3.79%)
BCTXL : 1.0000 (-3.85%)
BCTX : 4.13 (+3.51%)
BriaCell Reports Sustained Complete Resolution of Lung Metastasis in Bria-OTS™ Patient GlobeNewswire - Tue Jan 13, 6:30AM CST

[IMAGES BELOW] 11-month sustained complete resolution of lung metastasis observed in Bria-OTS Phase 1/2a metastatic breast cancer study. No treatment limiting toxicities reported. Patient maintained...

BCT.TO : 5.64 (+3.49%)
BCTXW : 0.0060 (+3.45%)
BCTXZ : 0.1453 (+3.79%)
BCTX : 4.13 (+3.51%)
“Eleven clinical trials that will shape medicine in 2026” – BriaCell Phase 3 Trial Featured in Nature Medicine GlobeNewswire - Thu Dec 18, 2025

Nature Medicine asked leading researchers to name their top clinical trial for 2026, from long-awaited vaccines for infectious diseases to new treatments for advanced cancers and long COVID BriaCell’s...

BCT.TO : 5.64 (+3.49%)
BCTXW : 0.0060 (+3.45%)
BCTXZ : 0.1453 (+3.79%)
BCTX : 4.13 (+3.51%)
BriaCell Presents Outstanding Phase 2 Survival & Promising Phase 3 Clinical Data at SABCS® 2025 GlobeNewswire - Wed Dec 10, 2025

BriaCell presents positive clinical data in three posters at the San Antonio Breast Cancer Symposium (SABCS ® ) Phase 3 study of Bria-IMT™ plus immune check point inhibitor (CPI) continues to...

BCT.TO : 5.64 (+3.49%)
BCTXW : 0.0060 (+3.45%)
BCTXZ : 0.1453 (+3.79%)
BCTX : 4.13 (+3.51%)

Barchart Exclusives

Kraft Heinz Pauses Its Breakup Plans. Should You Buy the High-Yield Dividend Stock Here? Barchart - 9 minutes ago
Kraft Heinz is still facing many tough challenges. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot